NONA
DGX icon

Ninety One North America’s Quest Diagnostics DGX Stock Holding History

Ninety One North America’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,158
Closed -$670K – 91
2017
Q3 		$670K Sell
7,158
-7,569
-51% -$804K 0.11% 74
2017
Q2 		$1.64M Buy
14,727
+966
+7% +$102K 0.3% 55
2017
Q1 		$1.35M Sell
13,761
-252
-2% -$24K 0.26% 60
2016
Q4 		$1.29M Sell
14,013
-162
-1% -$14K 0.19% 83
2016
Q3 		$1.2M Hold
14,175
– – 0.16% 94
2016
Q2 		$1.15M Buy
14,175
+2,000
+16% +$152K 0.17% 92
2016
Q1 		$870K Buy
12,175
+3,486
+40% +$234K 0.14% 95
2015
Q4 		$618K Hold
8,689
– – 0.11% 97
2015
Q3 		$534K Buy
8,689
+234
+3% +$16.4K 0.13% 100
2015
Q2 		$613K Hold
8,455
– – 0.2% 78
2015
Q1 		$650K Hold
8,455
– – 0.2% 77
2014
Q4 		$567K Buy
+8,455
New +$534K 0.17% 85

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Ninety One North America's DGX Position: Q4 2017 in Review

Ninety One North America sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 7,158 shares — an estimated $670K sold.

Ninety One North America first reported a position in DGX in Q4 2014 and held it in 12 quarters. The position peaked at $1.64M in Q2 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Ninety One North America reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Ninety One North America sold 7,158 Quest Diagnostics shares in Q4 2017, an estimated $670K.
  • Ninety One North America first reported a position in Quest Diagnostics in Q4 2014 and held it in 12 quarters.
  • Ninety One North America's Quest Diagnostics position peaked at $1.64M in Q2 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Ninety One North America's 13F filing for Q4 2017, filed 13 Feb 2018.